Monday, October 3, 2022


Biotechnology News Magazine

Maxim Biomedical Expands Sales and Marketing Organization

Company Adds WellTree Molecular Group as a new Distribution Partner

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Maxim Biomedical Inc. (MaximBio), the manufacturer of the ClearDetect™ COVID-19 Antigen Home Test (ClearDetect™), revealed changes to their Sales and Marketing organization, as well as the addition of an important new distribution partner: WellTree Molecular Group LLC (WellTree) of Atlanta, GA.

Jonathan Maa, MaximBio’s COO, announced that Stephen Sproul has joined MaximBio as Director of Sales and Marketing. Mr. Maa said that, “We are very excited to have Steve on our team. He is a proven leader with extensive experience in sales, sales management, and marketing. His success in launching novel diagnostics and his experience in establishing sales distribution channels in US and international markets makes him a great fit for our organization.”

MaximBio also announced that Anthony Morrison will be stepping down from his role as Chief Commercial Officer and will continue working with the company in an advisory role. Michael Topham, who had been serving as Sales and Marketing director will continue to provide marketing support, also in an advisory capacity.

The addition of WellTree Molecular Group as a distribution partner strengthens MaximBio’s presence in the diagnostics marketplace. WellTree, a women-owned company, prides themselves as a single source for diagnostic, consumables, and procurement. Steve Sproul, newly minted Director of Sales and Marketing described the value of the partnership, “With two warehouses located in Ontario, CA and Marietta, GA, WellTree will be able to support our efforts to get ClearDetect™ where it’s needed.” Renee Marchand, Chief Executive Officer at WellTree, agreed, “WellTree’s mission is to further, promote and deliver novel rapid diagnostic tests to point-of-care environments and we look forward to adding MaximBio and ClearDetect™ to our offering.”

Other executives on the move can be found here.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine